Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory IVIg Trial in Multifocal Motor Neuropathy (China)
ChiCTR2500106815Phase 4Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of immune globulin in multifocal motor neuropathy (MMN), sponsored by Xuanwu Hospital. Primary endpoint: Average grip strength and change from baseline between weeks 12 and 24. Planned start May 2025; status: not yet recruiting.
02
Drugs
immune globulin
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on ChiCTR2500106815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106815.